The feasibility and safety of dexmedetomidine and etomidate in gerontal patients undergoing ERCP

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004165

Enrollment

Unknown

Registered

2014-01-19

Start date

2014-01-03

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia

Interventions

propofol:propofol

dexmedetomidine:dexmedetomidine

dexmedetomidine+etomidate:dexmedetomidine+etomidate

Eligibility

Sex/Gender

All

Age

39 Years to 85 Years

Inclusion criteria

Inclusion criteria: ASA I ~ II level, aged 65 to 92 years old, weighing 52 ~ 89Kg, heart, lung, liver and kidney function was normal, no central nervous system disorders, obesity, snoring, etc.

Exclusion criteria

Exclusion criteria: ASA III ~ IV level, combined heart, lung, encephalopathy, uncooperative patient

Design outcomes

Primary

Measure	Time frame
blood gas;HR;SPO;	—

Countries

China

Contacts

Public ContactMan Wang

Tianjin Nankai Hospital

13502121665@163.com+86 13502121665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026